Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $522K 1,997 sh |
| Oct 15, 2026 traded Oct 13, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $862K 3,283 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $348K 1,320 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $394K 1,484 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $386K 1,544 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 9 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $258K 1,014 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer |  REGNREGENERON PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $207K 271 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $167K 219 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $163K 211 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $173K 224 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $51K 66 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $147K 192 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $218K 283 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $214K 279 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $81K 105 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $56K 74 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $94K 121 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 8 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $98K 127 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 7 | Eddy Robert W.Director, President & CEO |  BJBJ's Wholesale Club Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $517K 5,000 sh | Oct 15, 2026 traded Oct 15, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $220K 883 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $126K 476 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $54K 200 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $156K 600 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 6 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $171K 640 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $19K 25 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $4,523 6 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $21K 27 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $12K 16 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $39K 50 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $18K 24 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $30K 38 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $26K 35 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $11K 14 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $9,242 12 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 5 | Murphy Andrew JCo-Chief Scientific Officer | REGNREGENERON PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $42K 55 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 4 |  Huffman Steve LaddDirector, CEO & President, 10% Owner | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $662K 4,200 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 4 | Huffman Steve LaddDirector, CEO & President, 10% Owner | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $275K 1,700 sh | Oct 15, 2026 traded Oct 13, 2026 |
| 4 | Kumaraswami RaviPres. Worldwide Field Ops. |  RSKDRISKIFIED LTD.Open-market sale · 10b5-1 plan | SELL | $543K 65.0K sh | Oct 15, 2026 traded Oct 15, 2026 |
| 4 | Boughton SoleilChief Legal Officer |  HIMSHims & Hers Health, Inc.Open-market sale · 10b5-1 plan | SELL | $101K 3,461 sh | Oct 15, 2026 traded Oct 14, 2026 |
| 4 | Huffman Steve LaddDirector, CEO & President, 10% Owner | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $290K 1,800 sh | Oct 15, 2026 traded Oct 13, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K